Nanomix, Inc. to Webcast Corporate Presentation at the UBS Warburg Global Life Sciences Conference
9/19/2007 8:41:15 AM
EMERYVILLE, CA--(MARKET WIRE)--Sep 19, 2007 -- Nanomix, Inc., a leading nanoelectronic detection company commercializing high-value medical diagnostic and monitoring applications, today announced that President and CEO, David Macdonald, will present a corporate overview on Monday, September 24, 2007 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) during the UBS Global Life Sciences Conference. The conference is taking place at the Grand Hyatt New York in New York City. During his presentation, Mr. Macdonald will provide an overview of the Company's pipeline and Sensation(TM) detection platform. A breakout session for discussion will follow.
comments powered by